Refernce data for DPOAE in healthy newborns

Scandinavian Audiology

Volumn 29, Issue 2, 2000, Pages 79-82

  Gordts, F ^a   Naessens, B ^a   Mudde, C A ^b   Clement, P A R ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

Distortion products otoacoustic emissions; Hearing tests; Newborn

Indexed keywords

AMPLITUDE MODULATION; ARTICLE; DISTORTION PRODUCT OTOACOUSTIC EMISSION; EVOKED OTOACOUSTIC EMISSION; FEMALE; FREQUENCY DISCRIMINATION; HEARING IMPAIRMENT; HEARING TEST; HUMAN; HUMAN EXPERIMENT; MALE; NEWBORN; NORMAL HUMAN; PRIORITY JOURNAL; REFERENCE VALUE; AUDITORY STIMULATION; COCHLEA; COMPARATIVE STUDY; HEALTH STATUS; METHODOLOGY; PHYSIOLOGY; SPONTANEOUS OTOACOUSTIC EMISSION;

ACOUSTIC STIMULATION; COCHLEA; FEMALE; HEALTH STATUS; HUMANS; INFANT, NEWBORN; MALE; OTOACOUSTIC EMISSIONS, SPONTANEOUS;

EID: 0033623723     PISSN: 01050397     EISSN: None     Source Type: Journal    
DOI: 10.1080/010503900424480     Document Type: Article

References (15)

1. Abdala C. Distortion Product Otoacoustic Emission (2f1-f2) amplitude as a function of f2/f1 frequency ratio and primary tone level separation in human adults and neonates. J Acoust Soc Am 1996, 100: 3726-40.
2. Aidan D, Lestang P, Avan P, Bonfils P. Characteristics of Transient Evoked Otoacoustic Emissions (TEOAE) in neonates. Acta Otolaryngol (Stockh.) 1997; 117: 25-30.
3. ASHA (American Speech-Language-Hearing Association) (December 1994) Joint Committee on Infant Hearing 1994 Position Statement. Asha, 1994; 36: 38-41.
4. Engdahl B, Arnesen R, Mair IWS. Otoacoustic emissions in the first year of life. Scand Audiol 1994; 23: 195-200.
5. Hall JW, Baer JE, Chase PA, Schaber MK. Clinical applications of otoacoustic emissions: what do we know about factors influencing measurement and analysis? Otolaryngol Head and Neck Surg 1994; 110: 22-38.
6. Khalfa S, Morlet T, Micheyl C, Morgon A, Collet L. Evidence of peripheral hearing asymmetry in humans : clinical applications. Acta Otolaryncol (Stockh) 1997; 117: 192-6.
7. Marco J, Morant A, Caballero J, Orteils I, Paredes C, Brines J. Distortion Product Otoacoustic Emissions in healthy newborns: normative data. Acta Otolaryngol (Stockh) 1995; 115: 187-9.
8. Meredith R, Stephens D, Hogan S, Cartlidge PHT, Drayton M. Screening for hearing loss in at-risk neonatal population using Evoked Otoacoustic Emissions. Scand Audiol 1994; 23: 187-93 (Author - 1993 in text) .
9. Morlet T, Collet L, Duclaux R, Lapillonne A, Salle B, Putet G, Morgon A. Spontaneous and evoked otoacoustic emissions in pre-term and full-term neonates: is there a clinical application? Int J Ped Otolaryngol 1995a; 33: 207-11.
10. Morlet T, Lapillonne A, Ferber C, Duclaux R, Sann L, Putet G, et al. Spontaneous otoacoustic emissions in pretrerm neonates: prevalence and gender effect. Hear Res 1995b; 90: 44-54.
11. Moulin A, Collet L, Veuillet E, Morgon A. Interrelations between transiently evoked otoacoustic emissions, spontaneous otoacoustic emissions and acoustic distortion products in normally hearing subjects. Hear Res 1993; 65: 216-33.
12. Moulin A, Bera J-Ch, Collet L. Distortion Product Otoacoustic Emissions and sensorinearal hearing loss. Audiol 1994; 33: 305-26.
13. Solberg HE. Approved recommendation (1987) on the theory of reference values, part 2, Statistical treatment of collected reference values. Determination of reference limits. Clinica Chim Acta 1987; 170: S33-42.
14. Sun XM, Jung MD, Kim DO, Randolph KJ. Distortion product otoacoustic emission test of sensorineural hearing loss in humans: comparison of unequal- and equal-level stimuli. Ann Otol Rhinol Laryngol 1996; 105: 982-90.
15. Stover L, Gorga MP, Neely ST, Montoya D. Toward optimizing the clinical utility of distortion product otoacoustic emission measurements. J Acoust Soc Am 1996; 100: 956-67.